Novel anti-diabetic drugs such as glucagon-like peptide-1 (GLP-1) receptor agonists, sodium glucose co-transporter 2 inhibitors and dipeptidyl peptidase 4 (DPP-4) inhibitors have demonstrated some protective effects against ocular conditions, including glaucoma
2003;41(5 suppl):1117
Administration of exendin-4 ameliorated stress-induced defecation, decreased visceral pain sensitivity and increased the serum level of anti-inflammatory cytokine: interleukin-13 in the WistarKyoto rat strain, which was considered a model for irritable bowel syndrome [116]
Oxygen, Insulin Toxicity, Inflammation, and the Clinical Benefits of Chelation
These sessions allow you to review your bi-weekly results with your provider team, helping identify which lifestyle changes are working and where tweaks might be needed
GLP-1RAs are highly effective medications used to treat T2D and obesity while simultaneously conferring protection against cardiovascular disease, kidney disease, and hepatic steatosis in these patients